格列美脲治疗新发老年2型糖尿病有效性和安全性的观察(2)
 |
| 第1页 |
参见附件。
[参考文献]
[1] Kramer W，Muller G，Girbig F，et al.Differential interaction of glimepiride and glibenclamide with theβ-cell sulfonylurea receptor.Photoaffinity labeling of a 65 Kda protein by[3H]glimepiride[J].Biochim Biophys Acta，1994，1191(3)：278.
[2] 郭晓惠.格列美脲T2DM初始降糖药(GREAT研究)[N].中国医学论坛报，2011-12-16(8).
[3] Eliaschewitz FG，Calvo C，Valbuena H，et al.Therapy in type 2 diabetes：insulin glargine vs.NPH insulin both in combination with glimepiride[J].Arch Med Res，2006，37(4)：495-501.
[4] Arai K，Matoba K，Hirao K，et al.Present status of sulfonylurea treatment for type 2 diabetes in Japan：second report of a cross-sectional survey of 15，652 patients[J].Endocr J，2010，57(6)：499-507.
[5] Bugos C，Austin M，Atherton T，et al.Long-term treatment of type 2 diabetes mellitus with glimepiride is weight neutral：a multicentre retrospective cohort study[J].Diabetologia，2003，46：1611-1617.
[6] Davis SN.The role of glimepiride in the effective management of type 2 diabetes[J].J Diabetes Complications2004，18：367-376.
[7] Xu DY，Zhao SP，Huang QX，et al.Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus[J].Diabetes Res Clin Pract，2010，88(1)：71-75.
[8] Nagayama D，Saiki A，Endo K，et al.Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients[J].Int J Clin Pract，2010，64(13)：1796-801.
[9] Massi-Benedetti M.Glimepiride in type 2 diabetes mellitus：a review of the worldwide therapeutic experience[J].Clin Ther，2003，25：799-861.
(收稿日期：2012-08-03)
您现在查看是摘要介绍页，详见PDF附件。